News und Analysen
![Why Dialysis Stocks Plunged Today: https://g.foolcdn.com/editorial/images/750599/retired-man-undergoing-chemotherapy-cancer-health-sick.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnlzYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f6ffc3593b48ce8b7c63aaf264e707055147d1d0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/retired-man-undergoing-chemotherapy-cancer-health-sick.jpg?locale=de)
Why Dialysis Stocks Plunged Today
Shares of several major dialysis stocks plunged on Wednesday after Novo Nordisk (NYSE: NVO) indicated one of its diabetes treatments could also be used to treat chronic kidney disease.
Dialysis
![Why Shares of Fresenius Medical Care Were Dropping on Wednesday: https://g.foolcdn.com/editorial/images/750606/senior-patient-looking-through-window-at-hospital.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNjJzYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--db9cdc533e6b6a8adfa9f27882b21a961a014cff/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/senior-patient-looking-through-window-at-hospital.jpg?locale=de)
Why Shares of Fresenius Medical Care Were Dropping on Wednesday
Shares of Fresenius Medical Care (NYSE: FMS) were down more than 18% as of noon ET on Wednesday. The healthcare company's shares are up a little more than 5% so far this year. The drop came because
![Ozempic Is Moving a Bunch of Stocks Wednesday Morning: https://g.foolcdn.com/editorial/images/750574/drug-research-getty.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM3FzYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--483d72e2da7759db11072488fd2d70aa37b05337/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/drug-research-getty.jpg?locale=de)
Ozempic Is Moving a Bunch of Stocks Wednesday Morning
Stock markets looked poised to continue their winning ways on Wednesday morning, as stock index futures were higher across the board. Investors will get a look today at the latest thought process
![3 Reasons to Buy Merck Stock: https://g.foolcdn.com/editorial/images/747562/patient-and-doctor-talking.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMytaYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dd8e9173ffeb4f33785b88084a1b0f7cd156df13/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/patient-and-doctor-talking.jpg?locale=de)
3 Reasons to Buy Merck Stock
Pharmaceutical giant Merck (NYSE: MRK) has delivered excellent returns to its shareholders over the past 12 months, as last year's downturn did little to slow the drugmaker. The company's solid
![Agriculture Titans Are In a Head-to-Head Battle for America's Soy Farmers: https://g.foolcdn.com/editorial/images/747968/featured-daily-upside-image.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNWFUYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--fde9bc973669f189a46864346056d3a3fc21bf30/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/featured-daily-upside-image.jpg?locale=de)
Agriculture Titans Are In a Head-to-Head Battle for America's Soy Farmers
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
The US harvests
![Better Pharma Growth Stock: Eli Lilly vs. Merck: https://g.foolcdn.com/editorial/images/745466/businessmen-and-doctors-working-on-touchpad-in-a-hospital.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNzJBYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3885d97fc480f8146fde8552d1811641fd1310c2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/businessmen-and-doctors-working-on-touchpad-in-a-hospital.jpg?locale=de)
Better Pharma Growth Stock: Eli Lilly vs. Merck
Eli Lilly (NYSE: LLY) and Merck (NYSE: MRK) are both among the largest biopharmaceutical businesses in the world, but their growth prospects aren't exactly the same. Nonetheless, the pair handily
![My Oh My, Merck Stock Is a No-Brainer Income Stock to Buy: https://g.foolcdn.com/editorial/images/743074/a-pharmacist-serves-a-customer.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL3h1YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e3fccd4a04c98c4cfcf4e9a797281fc2830564dd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/a-pharmacist-serves-a-customer.jpg?locale=de)
My Oh My, Merck Stock Is a No-Brainer Income Stock to Buy
Investing for income may never be the most exciting investment strategy in the world. But as long as a company doesn't cut or suspend its dividend, it can be a profitable approach -- and some
![Is Merck Stock a Buy Now?: https://g.foolcdn.com/editorial/images/743032/doctor-with-patient-talking.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM3h1YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e86f94a626cd6ad0c75fe531279ae94d403fb8c7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/doctor-with-patient-talking.jpg?locale=de)
Is Merck Stock a Buy Now?
Merck (NYSE: MRK) has performed poorly in the stock market this year, with the drugmaker's shares down by 5%. But zooming out helps put a different spin on this story as the pharmaceutical giant has
![EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investmentshttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBHUT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--30a4f87e2f6442a34d491960296cefece4f65ecc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/carl_zeiss_meditec_logogif.png?locale=de)
EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
![Merck (MRK) Q2 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeSt3V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9dfca4603c1fc3af5c96a68f8938e1fa8ce6aed8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/featured-transcript-logo-template-2023-01-12.jpg?locale=de)
Merck (MRK) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Merck (NYSE: MRK)Q2 2023 Earnings CallAug 01, 2023, 8:00 a.m. ET
Operator
Source Fool.com
EQS-Adhoc: Bayer Aktiengesellschaft: Bayer lowers full-year outlook
![Why Shares of Fresenius Medical Jumped This Week: https://g.foolcdn.com/editorial/images/739861/doctors-white-coat-healthcare-1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemhQYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7da8a4caf44033fa231831b618237fbb5a0531ad/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/doctors-white-coat-healthcare-1.jpg?locale=de)
Why Shares of Fresenius Medical Jumped This Week
Shares of Fresenius Medical Care (NYSE: FMS) were up more than 11% for the week as of Friday at 1:30 p.m. ET, according to data provided by S&P Global Market Intelligence. The German healthcare
![Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks: https://g.foolcdn.com/editorial/images/737483/a-person-holding-money.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOGMvYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1e757d2f232e521ffadfb5d32db5c8e187d698ab/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/a-person-holding-money.jpg?locale=de)
Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks
Whether you're saving for retirement, want to set aside money for travel, or just want to give yourself a raise, dividend stocks can help give you some extra income to accomplish those goals. Plus
![Drug Maker Merck Sues US Gov. Over Inflation Reduction Act: https://g.foolcdn.com/editorial/images/735406/featured-daily-upside-image.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnNuYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--09e79dcd414bec0345172d9754552dda91f5618e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/featured-daily-upside-image.jpg?locale=de)
Drug Maker Merck Sues US Gov. Over Inflation Reduction Act
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
The war on drug
![Why NovoCure Stock Is Crashing Today: https://g.foolcdn.com/editorial/images/735284/novocure-person-with-ttfields-on-head.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMEVuYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--4d9d79283556d1af6ff71fb5360cc6face677b38/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/novocure-person-with-ttfields-on-head.jpg?locale=de)
Why NovoCure Stock Is Crashing Today
Shares of NovoCure (NASDAQ: NVCR) were crashing 29.6% lower as of 10:19 a.m. ET on Tuesday. The steep decline came after the company announced data for its Tumor Treating Fields (TTFields) therapy
EQS-AGM: Fresenius Medical Care AG & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 14.07.2023 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
![Why Shares of Iovance Biotherapeutics Jumped Tuesday: https://g.foolcdn.com/editorial/images/734441/doctors-white-coat-healthcare.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOVllYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--53675940ae9c49894c30c750e87b5751da64e2a6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/doctors-white-coat-healthcare.jpg?locale=de)
Why Shares of Iovance Biotherapeutics Jumped Tuesday
Shares of Iovance Biotherapeutics (NASDAQ: IOVA) were up more than 17% late Tuesday afternoon after the clinical-stage biotech company announced that the Food and Drug Administration (FDA) had
![2 No-Brainer Stocks to Buy Right Now for Less than $30: https://g.foolcdn.com/editorial/images/733901/using-a-stethoscope-listen-to-the-heartbeat-of-patient.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNkFiYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--76fbd92ed9f9edeeb91d913c3f87dc63a9c2f0ae/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/using-a-stethoscope-listen-to-the-heartbeat-of-patient.jpg?locale=de)
2 No-Brainer Stocks to Buy Right Now for Less than $30
Affordably priced shares -- typically seen as those trading under $30 on a per-share basis -- are a rarity among large companies with stable long-term growth prospects. That's because the market
![EQS-News: Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earningshttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBHUT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--30a4f87e2f6442a34d491960296cefece4f65ecc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/carl_zeiss_meditec_logogif.png?locale=de)
EQS-News: Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings
![2 Top Healthcare Stocks Defying the Bear Market: https://g.foolcdn.com/editorial/images/730875/pharmaceutical-factory-worker.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK1VDYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5bedda657c36b07cea54c2dd8b92717b4e51b4a8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/pharmaceutical-factory-worker.jpg?locale=de)
2 Top Healthcare Stocks Defying the Bear Market
Eli Lilly (NYSE: LLY) and Merck (NYSE: MRK) have seen their shares rise by over 17% and 5%, respectively, this year while the S&P 500 Health Care Sector Index has dropped 1.7%. What's interesting
![EQS-Adhoc: Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBHUT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--30a4f87e2f6442a34d491960296cefece4f65ecc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/carl_zeiss_meditec_logogif.png?locale=de)
EQS-Adhoc: Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23
EQS-AGM: Fresenius Medical Care AG & Co. KGaA: Announcement of the Convening of the General Meeting in Virtuelle Hauptversammlung ohne physische Präsenz der Aktionäre oder ihrer Bevollmächtigten on 16.05.2023 according to article 121 AktG (German St
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft)
![EQS-News: Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain highhttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBHUT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--30a4f87e2f6442a34d491960296cefece4f65ecc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/carl_zeiss_meditec_logogif.png?locale=de)